The efficacy of levobupivacaine, ropivacaine and bupivacaine for combined psoas compartment - sciatic nerve block in patients undergoing total hip replacement.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27060

Enrollment

Registered

2007-05-31

Start date

2003-06-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Total Hip Replacement (NLD: Totale Heup Prothese)

Interventions

Psoas Compartment - Sciatic Nerve Block given with Bupivacaine, Levobupivacaine or Ropivacaine. Duration of the intervention: 10 min.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age above 18; 2. ASA classification I-III; 3. Total Hip Replacement under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Co-agulation disorders; 2. Infections at puncture sites; 3. Known allergy to local anesthetics; 4. Pre-existing neurological dysfunction; 5. Not been able to proper communication.

Design outcomes

Primary

Measure	Time frame
Pain (Visual Analog Scale) op T = 4,8,12,24,48 hour post - puncture.	—

Secondary

Measure	Time frame
1. Degree of motor block (Modified Bromage Scale).op T = 4,8,12,24,48 hour post - puncture; 2. Degree of sensory block (Loss of pin-prick sensation in leg dermatomes) op T = 4,8,12,24,48 hour post - puncture.	—

Contacts

Public ContactRoberto S.G.M. Perez

VU medisch centrum, Anesthesiologie postbus 7057

rsgm.perez@vumc.nl+31 20-4440029.

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)